Eli Lilly Teams Up With Amazon to Sell New Weight Loss Drug Amid Shortages

Eli Lilly partners with Amazon to sell its new weight loss drug Zepbound directly to consumers amid shortages
Zepbound belongs to the GLP-1 class of drugs that includes the popular diabetes medication Ozempic
Eli Lilly and Novo Nordisk, maker of Ozempic, have struggled to meet demand for their weight loss drugs
The FDA has received adverse event reports related to compounded or altered versions of these medications
In addition to Zepbound, weight loss drugs like Wegovy, Saxenda are available online with a prescription